Ondansetron Tablet, Orally Disintegrating
Product Images NDC 71335-2972

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 71335-2972). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (E887abe7 4443 4b77 8e84 4c7cc0098e94 01)

Mm1 (E887abe7 4443 4b77 8e84 4c7cc0098e94 01)
Chemical structure diagram of Ondansetron showing its molecular framework with rings and functional groups as seen in the product's active ingredient.*
FDA Label Image

Label (Lbl713352972)

Label (Lbl713352972)
The label displays Zofran 4 mg orally disintegrating tablets (ODT) repackaged by Bryant Ranch Prepack and manufactured by Ipca Laboratories Limited. The package contains 20 tablets with an NDC of 71335-2972-1. It includes storage instructions, a QR code for dosage information, and warnings about keeping tablets in a child-resistant container and not removing tablets until use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.